MX363057B - Cepa de e. coli f18 no patogenica y uso de la misma. - Google Patents

Cepa de e. coli f18 no patogenica y uso de la misma.

Info

Publication number
MX363057B
MX363057B MX2015000905A MX2015000905A MX363057B MX 363057 B MX363057 B MX 363057B MX 2015000905 A MX2015000905 A MX 2015000905A MX 2015000905 A MX2015000905 A MX 2015000905A MX 363057 B MX363057 B MX 363057B
Authority
MX
Mexico
Prior art keywords
coli
strain
pathogenic
idac
canada
Prior art date
Application number
MX2015000905A
Other languages
English (en)
Spanish (es)
Other versions
MX2015000905A (es
Inventor
Morris Fairbrother John
Nadeau Eric
Desautels Clarisse
Original Assignee
Prevtec Microbia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prevtec Microbia Inc filed Critical Prevtec Microbia Inc
Publication of MX2015000905A publication Critical patent/MX2015000905A/es
Publication of MX363057B publication Critical patent/MX363057B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MX2015000905A 2012-07-20 2013-07-18 Cepa de e. coli f18 no patogenica y uso de la misma. MX363057B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261674179P 2012-07-20 2012-07-20
PCT/CA2013/000660 WO2014012172A1 (en) 2012-07-20 2013-07-18 Non-pathogenic f18 e. coli strain and use thereof

Publications (2)

Publication Number Publication Date
MX2015000905A MX2015000905A (es) 2015-09-28
MX363057B true MX363057B (es) 2019-03-06

Family

ID=49948133

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015000905A MX363057B (es) 2012-07-20 2013-07-18 Cepa de e. coli f18 no patogenica y uso de la misma.

Country Status (17)

Country Link
US (3) US9453195B2 (enExample)
EP (1) EP2875121B1 (enExample)
JP (1) JP6278960B2 (enExample)
KR (1) KR102171028B1 (enExample)
CN (1) CN104736695B (enExample)
BR (1) BR112015001175B1 (enExample)
CA (1) CA2879155C (enExample)
DK (1) DK2875121T3 (enExample)
ES (1) ES2663019T3 (enExample)
HU (1) HUE036545T2 (enExample)
MX (1) MX363057B (enExample)
PH (1) PH12015500091B1 (enExample)
PL (1) PL2875121T3 (enExample)
PT (1) PT2875121T (enExample)
RS (1) RS57056B1 (enExample)
RU (1) RU2670882C9 (enExample)
WO (1) WO2014012172A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE036545T2 (hu) 2012-07-20 2018-07-30 Prevtec Microbia Inc Nem-patogén F18 E. coli törzs és alkalmazása
JP6731416B2 (ja) * 2015-02-11 2020-07-29 プレヴテック マイクロビア インコーポレイテッド 生きている大腸菌を埋め込むための改良された乾燥マトリクス、その製造方法及びその使用
KR101715625B1 (ko) * 2015-06-02 2017-03-13 대한민국(농림축산식품부 농림축산검역본부장) 부종병 독소를 생산하는 대장균, 이를 이용한 부종병 독소의 생산방법 및 이를 포함하는 돼지 부종병 예방용 백신 조성물
RU2749883C2 (ru) * 2016-06-14 2021-06-18 Эланко Кэнэда Лимитед Гранулированный корм для животных, содержащий кормовую добавку, способ его получения и применения
WO2019006246A1 (en) * 2017-06-30 2019-01-03 The Rockefeller University N-ACYL AMIDES DERIVED FROM THE HUMAN MICROBIOTE FOR THE TREATMENT OF A HUMAN DISEASE
CN107523529B (zh) * 2017-10-20 2021-03-12 林州中农颖泰生物肽有限公司 一种利用大肠杆菌生产肠杆菌肽的工艺及其应用
CN109628361B (zh) * 2018-11-27 2022-08-19 扬州大学 整合双拷贝功能性f4菌毛操纵子基因猪源益生菌ep1克隆株、构建方法及应用
CN109504643B (zh) * 2018-11-27 2022-06-10 扬州大学 整合四拷贝功能性f18菌毛操纵子基因的益生菌克隆株、构建方法及应用
CN114752531B (zh) * 2022-04-29 2023-05-26 扬州大学 一株同时表达f4和f18菌毛的猪源大肠杆菌无毒分离株及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125455C1 (ru) * 1996-09-25 1999-01-27 Саратовская научно-исследовательская ветеринарная станция Способ профилактики диареи молодняка сельскохозяйственных животных
US6355859B1 (en) 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
WO2000006764A1 (en) * 1998-07-30 2000-02-10 Wisconsin Alumni Research Foundation Gastrointestinal bacterial antibody factories
US6304216B1 (en) 1999-03-30 2001-10-16 Conexant Systems, Inc. Signal detector employing correlation analysis of non-uniform and disjoint sample segments
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
AU2002221004B2 (en) * 2000-11-30 2007-01-25 The Bio Balance Corp. Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
AU2003287028B2 (en) 2002-10-04 2008-09-04 E.I. Du Pont De Nemours And Company Process for the biological production of 1,3-propanediol with high yield
WO2005074706A1 (en) * 2004-02-03 2005-08-18 Universite De Montreal Use of live bacteria for growth promotion in animals
MXPA06013253A (es) * 2004-05-14 2007-02-28 Agtech Products Inc Metodo y composicion para reducir la enfermedad de e. coli disease y mejorar el rendimiento utilizando bacilos.
US7927586B2 (en) * 2008-07-08 2011-04-19 South Dakota State University Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli
HUE036545T2 (hu) 2012-07-20 2018-07-30 Prevtec Microbia Inc Nem-patogén F18 E. coli törzs és alkalmazása

Also Published As

Publication number Publication date
EP2875121A1 (en) 2015-05-27
MX2015000905A (es) 2015-09-28
HUE036545T2 (hu) 2018-07-30
CN104736695B (zh) 2017-05-24
WO2014012172A1 (en) 2014-01-23
US20160361369A1 (en) 2016-12-15
US20180008651A1 (en) 2018-01-11
CA2879155A1 (en) 2014-01-23
RU2670882C2 (ru) 2018-10-25
PT2875121T (pt) 2018-03-14
PH12015500091A1 (en) 2015-03-02
US9775867B2 (en) 2017-10-03
EP2875121B1 (en) 2018-01-03
JP6278960B2 (ja) 2018-02-14
PL2875121T3 (pl) 2018-06-29
KR20150036698A (ko) 2015-04-07
US9453195B2 (en) 2016-09-27
US10258654B2 (en) 2019-04-16
KR102171028B1 (ko) 2020-10-28
BR112015001175B1 (pt) 2022-03-03
RS57056B1 (sr) 2018-05-31
HK1209780A1 (en) 2016-04-08
RU2670882C9 (ru) 2018-12-11
ES2663019T3 (es) 2018-04-10
BR112015001175A2 (pt) 2017-06-27
DK2875121T3 (en) 2018-04-16
RU2015105738A (ru) 2016-09-10
CN104736695A (zh) 2015-06-24
US20150152377A1 (en) 2015-06-04
PH12015500091B1 (en) 2015-03-02
CA2879155C (en) 2024-04-30
JP2015525566A (ja) 2015-09-07
EP2875121A4 (en) 2016-01-13

Similar Documents

Publication Publication Date Title
MX363057B (es) Cepa de e. coli f18 no patogenica y uso de la misma.
ES2561253T3 (es) Bacterias probióticas que tienen actividad antioxidante y uso de las mismas
SA113340703B1 (ar) سلالة جديدة من بكتيريا Lactobacillus Crispatus
MX2021009001A (es) Composiciones microbianas para alimentacion directa y sus metodos de uso.
MX2021000285A (es) Composiciones que comprenden cepas bacterianas.
MX2018009660A (es) Composicion que comprende agentes de control biologico.
NZ777234A (en) Compositions comprising bacterial strains
MX395262B (es) Composición para usarse en el tratamiento de infección gastrointestinal.
EP4230644A3 (en) Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
UA109123C2 (uk) Пробіотична композиція для застосування в лікуванні запалення кишечнику
WO2012001075A3 (en) Immortalized avian cell lines
PH12015502216A1 (en) Compositions and methods for improving the health of aquatic animals
PH12015502416A1 (en) Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same
MX2020012061A (es) Composiciones que comprenden cepas bacterianas.
MX2015006942A (es) Composicion que comprende un agente de control biologico y un fungicida.
WO2014086753A3 (en) Composition comprising biological control agents
MX384834B (es) Novedoso bacteriófago esc-cop-1 de e. coli tipo f18 productora de toxina shiga y su uso para inhibir la proliferación de e. coli tipo f18 productora de toxina shiga
EA201290623A1 (ru) Лактобациллы с антиоксидантным действием
MX356959B (es) Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos.
BR112014000542A2 (pt) composições de peroxidase eosinofílica e métodos de uso das mesmas
WO2018004224A3 (ko) 신규 스포리치아과 미생물 및 그의 용도
SG11202000113QA (en) Composition comprising lactobacillus plantarum cjlp475 strain and lactobacillus plantarum cjlp243 strain and use thereof
WO2012138477A3 (en) Probiotic bacterial strains and method of use to decrease mortality due to bacterial disease
AR101538A1 (es) Cepas bacterianas que tienen actividad antimicrobiana y composiciones de biocontrol que las comprenden
MX2022005052A (es) Microorganismos resistentes a los fagos.